Ferric derisomaltose, sold under the brand name Monoferric, is a medication for the treatment of iron deficiency anemia (IDA) in adults who have intolerance to oral iron or have had unsatisfactory response to oral iron or who have non-hemodialysis dependent chronic kidney disease. It was approved for use in the United States in January 2020. It is given intravenously.
Attributes | Values |
---|---|
rdf:type | |
rdfs:label |
|
rdfs:comment |
|
dct:subject | |
Wikipage page ID |
|
Wikipage revision ID |
|
Link from a Wikipage to another Wikipage | |
Link from a Wikipage to an external page | |
sameAs | |
dbp:wikiPageUsesTemplate | |
ATC prefix |
|
c |
|
CAS number |
|
DrugBank |
|
H |
|
IUPAC name |
|
KEGG |
|
legal US |
|
O |
|
PubChem |
|
routes of administration | |
SMILES |
|
StdInChI |
|
StdInChIKey |
|
tradename |
|
UNII |
|
has abstract |
|
charge |
|
DailyMedID |
|
Fe |
|
legal CA |
|
prov:wasDerivedFrom | |
page length (characters) of wiki page |
|
alternative name |
|
CAS number |
|
DrugBank |
|
FDA UNII code |
|
KEGG |
|
PubChem |
|
foaf:isPrimaryTopicOf | |
is Link from a Wikipage to another Wikipage of | |
is Wikipage redirect of | |
is foaf:primaryTopic of |